{"organizations": [], "uuid": "8ebe75a9c93b9648173a140be320dd22f6c32edf", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews\r", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-mylan-biocon-get-approvals-from-eu/brief-mylan-biocon-get-approvals-from-european-commission-tga-australia-for-semglee-biosimilar-insulin-glargine-idUSFWN1R90VX", "country": "US", "domain_rank": 408, "title": "BRIEF-Mylan, Biocon get approvals from European Commission, TGA Australia for Semglee, Biosimilar Insulin Glargine", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-03-28T06:07:00.000+03:00", "replies_count": 0, "uuid": "8ebe75a9c93b9648173a140be320dd22f6c32edf"}, "author": "", "url": "https://www.reuters.com/article/brief-mylan-biocon-get-approvals-from-eu/brief-mylan-biocon-get-approvals-from-european-commission-tga-australia-for-semglee-biosimilar-insulin-glargine-idUSFWN1R90VX", "ord_in_thread": 0, "title": "BRIEF-Mylan, Biocon get approvals from European Commission, TGA Australia for Semglee, Biosimilar Insulin Glargine", "locations": [], "entities": {"persons": [], "locations": [{"name": "australia", "sentiment": "none"}, {"name": "australia", "sentiment": "none"}], "organizations": [{"name": "european commission", "sentiment": "negative"}, {"name": "biocon", "sentiment": "negative"}, {"name": "mylan nv", "sentiment": "none"}, {"name": "biosimilar insulin glargine reuters", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}, {"name": "mylan", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}, {"name": "tga australia for semglee", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "March 27 (Reuters) - Mylan NV:\n* MYLAN AND BIOCON RECEIVE APPROVALS FROM THE EUROPEAN COMMISSION AND TGA AUSTRALIA FOR SEMGLEEâ„¢, BIOSIMILAR INSULIN GLARGINE Source text for Eikon: Further company coverage:\n ", "external_links": [], "published": "2018-03-28T06:07:00.000+03:00", "crawled": "2018-03-28T06:17:14.021+03:00", "highlightTitle": ""}